The subjective experience of youth psychotropic treatment

Social Work in Mental Health

Volumn 1, Issue 4, 2004, Pages 51-69

  Floersch, Jerry ^a  

^a NONE

Author keywords

Adolescent; Child; Illness identity; Medication management; Psychotropic treatment

Indexed keywords

EID: 34248599811     PISSN: 15332985     EISSN: 15332993     Source Type: Journal    
DOI: 10.1300/J200v01n04_04     Document Type: Article

References (82)

1. Anderson, B., Ho, J., Brackett, J., Finkelstein, D., & Laffel, L. (1997). Parental involvement in diabetes management tasks: Relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. Journal of Pediatrics, 130: 257-265.
2. Bastiaens, L. (1995). Compliance with pharmacotherapy in adolescents: Effects of patients’ and parents’ knowledge and attitudes toward treatment. Journal of Child and Adolescent Psychopharmacology, 5(1): 39-48.
3. Biederman, J., Mick, E., Bostic, J. Q., Prince, J., Daly, J., Wilens, T. E., Spencer, T., Garcia-Jetton, J., Russell, R., Wozniak, J., & Faraone, S. V. (1998). The naturalistic course of pharmacologic treatment of children with manic like symptoms: A systematic chart review. Journal of Clinical Psychiatry, 59(Nov): 628-37.
4. Brown, R. T., Borden, K. A., Wynne, M. E., Spunt, A. L., & Clingerman, S. R. (1988). Patterns of compliance in a treatment program for children with attention deficit disorder. Journal of Compliance in Health Care, 3(1): 23-39.
5. Canino, I., Canino, G., & Arroyo, W. (1998). Cultural considerations for childhood disorders: How much was included in DSM-IV? Transcultural Psychiatry, 35: 343-356.
6. Charmaz, K. (1990). Discovering chronic illness: Using Grounded Theory. Social Science Medicine, 30(11), pp. 1161-1172.
7. Chernoff, R. G., Ireys, H. T., DeVet, K. A., & Young, K. J. (2002). A randomized, controlled trial of a community-based support program for families of children with chronic illness: Pediatric outcomes. Archives of Pediatric Adolescent Medicine, 156: 533-539.
8. Chewning, B. (1997). Patient involvement in pharmaceutical care: A conceptual framework. American Journal of Pharmaceutical Education, 61(4), 394-401.
9. Chewning, B., & Schommer, J. C. (1996). Increasing clients’ knowledge of community pharmacists’ roles. Pharmaceutical Research, 13(9), 1299-1304.
10. Chewning, B., & Sleath, B. (1996). Medication decision-making and management: A client-centered model. Social Science & Medicine, 42(3), 389-398.
11. Clarke, C. H. (1997). An exploratory study of the meaning of prescription medication to children diagnosed with attention deficit hyperactivity disorder. Ph.D. dissertation, Loyola University Chicago, Department of Social Work.
12. Cohen, D. (2002). Research on the drug treatment of schizophrenia: A critical appraisal and implications for social work education. Journal ofSocial Work Education, 38(2): 217-239.
13. Conrad, P. (1990). Qualitative research on chronic illness: A commentary on method and conceptual development. Social Science Medicine, 30(11): 1257-1263.
14. Conrad, P. (1985). The meaning of medications: Another look at compliance. Social Science Medicine, 20: 29-37.
15. Cromer, B. A., & Tarnowski, K. J. (1989). Noncompliance in adolescence: A review. Developmental Behavioral Pediatrics, 10(4): 207-215.
16. Emslie, G. J., Walkup, J. T., Pliszka, S. R., & Ernst, M. (1999). Nontricyclic antidepressants: Current trends in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 38(5): 517-528.
17. Estroff, Su. (1993). Identity, Disability, and Schizophrenia: The Problem of Chronicity. In S. Lindenbaum and Margaret Lock, Knowledge, Power, & Practice, pp. 247-286. Berkeley: University of California Press.
18. Findling, R. L., & Dogin, J. W. (1998). Psychopharmacology of ADHD: Children and adolescents. Journal of Clinical Psychiatry, 59: 42-49.
19. Findling, R. L., Schulz, S. C., Reed, M. D., & Blumer, J. L. (1998). The antipsychotics- A pediatric perspective. Pediatric Clinics of North America, 45(5): 1205-1232.
20. Firestone, P. (1982). Factors associated with children’s adherence to stimulant medication. American Journal of Orthopsychiatry, 52: 447-457.
21. Floersch, J. (2002). Meds, money, and manners: The case management ofsevere mental illness. New York: Columbia University Press.
22. Frankel, F., Cantwell, D. P., Myatt, R., & Feinberg, D. T. (1999). Do stimulants improve self-esteem in children with ADHD and peer problems? Journal of Child and Adolescent Psychopharmacology, 9(3): 185-194.
23. Furman, E. (2001) On being and having a mother. International Universities Press.
24. Gadow, K. (1997). An overview of three decades of research in pediatric psychopharmacology. Journal of Child and Adolescent Psychopharmacology, 7(4): 219-236.
25. Geller, B., Zimerman, B., Williams, M., DelBello, M.P., Bolhofner, K., Craney, J. L., (2002b). DSM-IV mania symptoms in a prepubertal and early adolescent bipolar phenotype compared to attention-deficit hyperactive and normal controls. Journal of Child and Adolescent Psychopharmacology, 12(1): 11-25.
26. Geller, B., Zimerman, B., Williams, M., DelBello, M. P., Frazier, J., & Beringer, L. (2002a). Phenomenology of prepubertal and early adolescent bipolar disorder: Examples of elated mood, grandiose behaviors, decreased need for sleep, racing thoughts, and hypersexuality. Journal of Child and Adolescent Psychopharmacology, 12(1): 3-9.
27. Ghaziuddin, N., King, C. A., Hovey, J. D., Zaccagnini, J., & Ghaziuddin, M. (1999). Medication noncompliance in adolescents with psychiatric disorders. Human Development, 30(2): 103-110.
28. Glasgow, R. E., & Anderson, B. J. (1995). Future directions for research on pediatric chronic disease management: Lessons from diabetes. Journal of Pediatric Psychology, 20: 389-402.
29. Greenhill, L. L. (1998). The use of psychotropic medication in preschoolers: Indications, safety, and efficacy. Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie, 43(6): 576-581.
30. Greenhill, L. L., Vitiello, B., Abikoff, H., Levine, J., March, J. S., Riddle, M. A., Capasso, L., Cooper, T., Davies, M., Fisher, P., Findling, R. L., Fried, J., Labellarte, M., McCracken, J., McMahon, D. J., Robinson, J., Skrobala, A. M., Scahill L., Walkup J., & Zito J. (2001). Improving the methods for evaluating the safety of psychotropic medications in children and adolescents. Current Therapeutic Research-Clinical and Experimental, 62(12): 873-884.
31. Gudas, L. J., Koocher, G. P., & Wypij, D. (1991). Perceptions of medical compliance in children and adolescents with cystic fibrosis. Developmental and Behavioral Pediatrics, 12: 236-242.
32. Harrop, C., & Trower, P. (2001). Why does schizophrenia develop at late adolescence? Clinical Psychology Review, 21(2): 241-266.
33. Henker, B., & Whalen, C. K. (1980). The many messages of medication: Hyperactive children’s perceptions and attributions. In S. Salzinger, J. Antrobus, & J. Glick (Eds), The ecosystem of sick child. New York: Academic Press.
34. Hoagwood, K., & Olin, S. S. (2002). The NIMH blueprint for change report: Research priorities in child and adolescent mental health. The Journal of the American Academy of Child and Adolescent Psychiatry, 41(7): 760-767.
35. Hohmann, A. A., & Shear, M. K. (2002). Community-based intervention research: Coping with the noise of real life in study design. American Journal of Psychiatry, 159(2): 201-207.
36. Horwitz, S. M., Leaf, P. J., & Leventhal, J. M. (1998). Identification of psychosocial problems in pediatric primary care: Do family attitudes make a difference? Archives of Pediatrics and Adolescent Medicine, 152: 367-371.
37. Ivers-Landis, C., & Drotar, D. (2000). Parental and child knowledge of the treatment regimen for childhood chronic illnesses. In D. Drotar (Ed.), Promoting adherence to medical treatment in chronic childhood illness: Concepts, methods and interventions, Mahwah, NJ: L. Erlbaum Assoc., pp. 259-282.
38. Jenkins, J. H. (1998). Diagnostic criteria for schizophrenia and related psychotic disorders: Integration and suppression of cultural evidence in DSM-IV. Transcultural Psychiatry, 35: 359-378.
39. Jenkins, J. H. (1997). Subjective experience of persistent psychiatric disorder: Schizophrenia and depression among U.S. Latinos and Euro-Americans. British Journal of Psychiatry, 170: 20-25.
40. Jenkins, J. H. (1994). The psychocultural study of emotion and mental disorder. In P. Bock (Ed.), Handbook of psychological anthropology. Westport, CT: Greenwood Publishers.
41. Jenkins, J. H., & Karno, M. (1992). The meaning of ‘expressed emotion’: Theoretical issues raised by cross-cultural research. American Journal of Psychiatry, 149: 9-21.
42. Jenkins, J. H. (1991). Anthropology, Expressed Emotion, and Schizophrenia. Ethos, 19(4): 387-431.
43. Jensen, P. S., Bhatara, V. S., Vitiello, B., Hoagwood, K., Feil, M., & Burke, L. B. (1999). Psychoactive medication prescribing practices for US children: Gaps between research and clinical practice. Journal of the American Academy of Child and Adolescent Psychiatry, 38(5): 557-565.
44. Jensen, P. S. (1998). Ethical and pragmatic issues in the use of psychotropic agents in young children. Canadian Journal of Psychiatry Revue Canadienne De Psychiatrie, 43(Aug): 585-588.
45. Kaplan, S. L., Simms, R. M., & Busner, J. (1994). Prescribing practices of outpatient child psychiatrists. Journal of the American Academy of Child and Adolescent Psychiatry, 33(1): 35-44.
46. Karp, D. A. (1996). Speaking of sadness: Depression, disconnection, and the meanings of illness. New York: Oxford University Press.
47. Kirmayer, L. J. (1998). Editorial: The fate of culture in DSM-IV. Transcultural Psychiatry, 35: 339-342.
48. Kleinman, A. (1988). The illness narratives: Suffering, healing, and the human condition. New York: Basic Books.
49. Leff, J., & Vaughn, C. (Eds.) (1985). Expressed emotion in families. New York: Guilford Press.
50. Lewis-Fernandez, R. (1998). A cultural critique of the DSM-IV dissociative disorders section. Transcultural Psychiatry, 35: 387-400.
51. Longhofer, J., Floersch, J., & Jenkins, J. H. (2003). The Social Grid of Community Medication Management. American Journal of Orthopsychiatry, 73(1): 24-34.
52. Manson, S., & Kleinman, A. (1998). DSM-IV, culture and mood disorders: A critical reflection on recent progress. Transcultural Psychiatry, 35: 377-386.
53. Minde, K. (1998). The use of psychotropic medication in preschoolers: Some recent developments. Canadian Journal ofPsychiatry-Revue Canadienne De Psychiatrie, 43(6): 571-575.
54. Ochs, E., & Capps, L. (1996). Narrating the self. Annual Review of Anthropology, 25:19-43.
55. Pincus, H. A., Tanielian, T. L., Marcus, S. C., Olfson, M., Zarin, D. A., Thompson, J., & Zito, J. M. (1998). Prescribing trends in psychotropic medications: Primary care, psychiatry, and other medical specialities. Journal ofAmerican Medical Association, 279(7): 526-531.
56. Pliszka, S. R., Greenhill, L. L., Crismon, M. L., Sedillo, A., Carlson, C., Conners, C. K., McCracken, J. T., Swanson, J. M., Hughes, C. W., Llana, M. E., Lopez, M., Toprac, M. G., & Texas Consensus Conference, Panel On Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. (2000). The Texas children’s medication algorithm project: Report of the Texas consensus conference panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part I. Journal of the American Academy of Child and Adolescent Psychiatry, 39(7): 908-919.
57. Rappaport, N., & Chubinsky, P. (2000). The meaning of psychotropic medications for children, adolescents, and their families. Journal of American Academy of Child and Adolescent Psychiatry, 39(9): 1198-1200.
58. Riddle, M. A., Kastelic, E. A., & Frosch, E. (2001). Pediatric psychopharmacology. Journal of Child Psychology and Psychiatry and Allied Disciplines, 42 (Jan): 73-90.
59. Riessman, C.K. (1990). Strategic uses of narrative in the presentation of self and illness. Social Science and Medicine, 30 (11): 1195-1200.
60. Ryan, N. D., Bhatara, V. S., & Perel, J. M. (1999). Mood stabilizers in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 38(5): 529-536.
61. Safer, D. J., & Krager, J. M. (1988). A Survey of Medication Treatment for hyperactive/inattentive students. Journal of American Medical Association, 260(15): 2256-2258.
62. Safer, D. J., Zito, J. M., & Fine, E. M. (1996). Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics, 98(6 pt. 1): 1084-1088.
63. Sayer, A. (2000). Realism and Social Science. London: Sage Publications.
64. Schirm, E., Tobi, H., Zito, J. M. & (2001). Psychotropic medication in children: A study from the Netherlands. Pediatrics, 108(2): 30-33.
65. Shapiro, T. (1996). Developmental considerations in psychopharmacology: The interaction of drugs and development. In J.M. Weiner (Ed.), Diagnosis and Psychopharmacology of childhood and adolescent disorders, pp. 79-95. New York: John Wiley & Sons, Inc.
66. Sleath, B. (1996). Pharmacist-patient relationships: Authoritarian, participatory, or default? Patient Education and Counseling, 28, 253-263.
67. Sleath, B., Svarstad, B., & Roter, D. (1997). Physician vs patient initiation of psychotropic prescribing in primary care settings: A content analysis of audiotapes. Social Science and Medicine, 44(4), 541-548.
68. Sleator, E. K., Ullmann, R. K. & von Neumann, A. (1982). How do hyperactive children feel about taking stimulants and will they tell the doctor? Clinical Pediatrics, 21(8): 474-479.
69. Stone, Deborah. (1984). The disabled state. Philadelphia: Temple University Press.
70. Strauss, J. S. (1989). Subjective experiences of schizophrenia: Toward a new dynamic psychiatry-II. Schizophrenia Bulletin, 15(2): 179-187.
71. Thuppal, M., Carlson, G. A., Sprafkin, J., & Gadow, K. (2002). Correspondence between adolescent report, parent report, and teacher report of manic symptoms. Journal of Child and Adolescent Psychopharmacology, 12(1): 27-35.
72. Tosyali, M. C., & Greenhill, L. L. (1998). Child and adolescent psychopharmacology- Important developmental issues. Pediatric Clinics of North America, 45(5): 1021-1035.
73. Tyson, P., & Tyson, R. L. (1990). Psychoanalytic theories of development: An integration. New Haven: Yale University Press.
74. Vitiello, B. (2001). Psychopharmacology for young children: Clinical needs and research opportunities. Pediatrics, 108(Oct): 983-9.
75. Vitiello, B. (1998). Pediatric psychopharmacology and the interaction between drugs and the developing brain. Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie, 43(6): 582-584.
76. Walkup, J. T., Cruz, K., Kane, S., & Geller, B. (1998). The future of pediatric psychopharmacology. Pediatric Clinics of North America, 45(5): 1265-1278.
77. Werry J. S., McClellan, J. M., & Chard, L. (1991). Childhood and adolescent schizophrenic, bipolar, and schizoaffective disorders: A clinical and outcome study. Journal American Academy of Child and Adolescent Psychiatry, 30: 457-465.
78. Wilens, T. E. (1999). Straight Talk about Psychiatric Medications for Kids. New York: Guilford Press.
79. Zito, J. M., & Safer, D. J. (2001). Services and prevention: Pharmacoepidemiology of antidepressant use. Biological Psychiatry, 49(12): 1121-1127.
80. Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Boles, M., & Lynch, F. (2000). Trends in the prescribing of psychotropic medications to preschoolers. JAMA-Jour- nal of the American Medical Association, 283(8): 1025-1030.
81. Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Magder, L., Soeken, K., Boles, M., Lynch, F., & Riddle, M. A. (2003). Psychotropic practice patterns for youth. Archives of Pediatrics & Adolescent Medicine, 157 (1): 17-25.
82. Zito, J. M., Safer, D.J., dosReis, S., Gardner, J. F., Soeken, K., Boles, M., & Lynch, F. (2002). Rising prevalence of antidepressants among US youths. Pediatrics, 109(5): 721-727.